ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: PP11

We Suffered For Decades, But Then She Was Born

Ian Stedman1 and Barbara Stedman2, 1Canadian Autoinflammatory Network, Vaughan, ON, Canada, 2Canadian Autoinflammatory Network, Turkey Point, ON, Canada

Meeting: ACR Convergence 2023

Keywords: Autoinflammatory diseases, genetics, Inflammasome, Pediatric rheumatology, quality of life

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: Patient Perspectives Poster

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: I was born in 1981; my mother in 1949; and my grandmother in 1926. Our story runs at least four generations deep, that we know of.

I began visiting my family doctor at 2 years of age for various issues, including swollen joints, bloodshot eyes, unexplained rashes, fevers, and debilitating headaches. My symptoms lasted from a half day to three days, with no patterns or triggers. My mother had the same challenges, as did her mother.

My childhood was defined by an endless search for answers. We rushed from specialist to specialist and spent long hours in waiting rooms to endure never-ending tests. I was prescribed anti-inflammatories, antihistamines, pain meds, but never accurately diagnosed. Doctors treated my symptoms, yet never suggested they might be connected.

By my late teens I lost interest in continuing the “specialist shuffle”. I took the medicines I was prescribed and adjusted my lifestyle as needed. I missed school. I missed sports. I missed activities with friends. I accepted that my normal was not everyone’s.

Intervention: Everything changed in 2012 when our first daughter was born. Like many babies, she had a rash at birth. Hers was different though. Like mine, it would go away and come back. It covered her body and sometimes her face, and she even experienced joint problems. Although I had given up looking for answers ten years earlier, it became clear that I didn’t have that right anymore.

My diagnostic odyssey re-started, I spent nights reading medical journals to no avail. Desperate, I searched online for images of rashes and found a blog. The blogger described his diagnosis and posted pictures of his rash. It looked like ours! I headed back to the journals, made a plan, visited more specialists, then had my eureka moment – I think we have Muckle Wells Syndrome! I searched for physicians who knew this rare disease and cold emailed a rheumatologist at our children’s hospital. That rheumatologist responded within hours and asked me to obtain a referral.

Back to the hospital for more questions and tests. This time our blood was sent for genetic analysis and three months later we confirmed that we have Muckle Wells Syndrome (MWS). We learned that if left untreated, MWS can cause amyloidosis and sometimes lead to death.

Maintenance: Luckily, effective therapies were available. My mother, daughter and I now take an anti-IL-1b monoclonal antibody every 8 weeks. Our symptoms went away overnight and my daughter does have to live the same life that we did. I was in complete disbelief after that first dose and struggled for months to accept our “new normal”. I feared it might be temporary, so I took nothing for granted.

Quality of Life: Treatment has changed our lives. It transformed my sense of what I am capable of and inspired me to think deeply about what I am responsible for. I am lifted each morning knowing that I am no longer limited by my health. I joined the board of a national rare disease advocacy group, which broadened my perspectives. I went back to University, earned my PhD in law and became a professor. I have testified before Canada’s House of Commons Committee on Health and even co-founded a not-for-profit to help bring awareness to these diseases. MWS is merely one of 60+ gene mutations that have been described in the field of autoinflammation. Everyone should know them!

Supporting image 1

Image of skin on daughter’s legs and left arm.

Supporting image 2

Image of author’s legs.


Disclosures: I. Stedman: None; B. Stedman: None.

To cite this abstract in AMA style:

Stedman I, Stedman B. We Suffered For Decades, But Then She Was Born [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/we-suffered-for-decades-but-then-she-was-born/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/we-suffered-for-decades-but-then-she-was-born/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology